Back

Advisory Committees

Advisory Committees

Recipient Representatives Advisory Committee

"It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committees be created to facilitate the work of the national blood service:

A Recipient Representatives Advisory Committee, consisting of representatives of community and consumer organizations. This committee should ensure that special interests are brought to the attention of the board and that there is adequate communication between the national blood service and any pertinent external organizations, including community and national organizations for recipients, public health organizations, and national and international health and blood-banking organizations. It should also advise the board about the development of educational material for donors and consumers."

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final report, Volume 3, p. 1055.

  • Establish effective lines of communication between Héma-Québec and the various groups representing recipients of products;
  • Bring their particular interests to the attention of the Board of Directors;
  • Advise Héma-Québec on its communication with other interested parties regarding any development and/or change in the supply system that could affect them;
  • Allow committee members to present their position on any topic of interest to them;
  • Advise the Board of Directors as well as the Management Committee on risk management with respect to aspects that may affect recipients.
The committee is composed of a minimum of ten (10) external members entitled to vote. The Board of Directors appoints the external members among the candidates recommended by organizations combining the interests of the recipients.
Organizations
Canadian Hemophilia Society - Québec chapter
Association des patients immunodéficients du Québec
LEUCAN
Canadian Transplant Association
Leukemia and Lymphoma Society of Canada
Québec Sickle Cell Association
COCQ-sida

Scientific and Medical Advisory Committee

"It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committees be created to facilitate the work of the national blood service:

A scientific and medical advisory committee, to keep abreast of the frequent and rapid technical and scientific developments that affect the blood supply system. This committee should ensure that the board of directors always has current information about scientific developments. It should also advise the board about the expenditure of the research funds for the blood supply system and should monitor technical developments affecting the blood supply system, including alternatives to blood components and blood products, and methods of improving the safety and efficacy of blood components and blood products."

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final Report, Volume 3, p. 1055.

  • Advise the Board of Directors on scientific and medical developments that might have an impact on the supply of products, particularly technological developments, therapeutic effectiveness and substitutes;
  • Assess the scientific relevance, status and quality of work in all research and development programs, with the exception of projects in cell and tissue therapy production, and to advise the Board of Directors;
  • Monitor the implementation of policies and procedures with regard to research and development.

The committee is composed of a minimum of ten (10) external voting members, including a representative from Canadian Blood Services. The Board of Directors appoints the external members after reviewing their curriculum vitae with the exception of one member appointed by the Advisory Committee of Recipients' Representatives.
Conflicts of interest (organization and intellectual property) should be avoided in the selection of members. The member selection process must take into account the following fields:

Fields
Transfusion medicine
Hematopoiesis
Plasma derivatives
Blood component manufacturing
Diagnostic technologies
Molecular biology
Immunology
Biotechnology
Industrial research
Human tissue and sickle cells

Safety Advisory Committee

“It is recommended that, in addition to the customary committees of a corporate board of directors, the following standing committee be created to facilitate the work of the national blood service:

A safety committee, consisting of persons from the fields of infectious diseases, epidemiology, public health, medicine, and blood banking, as well as consumers. The purpose of the committee is to advise the board about the safety of the blood supply, including existing and emerging pathogens. It should also assist the board in the process of risk assessment.”

Mr. Justice Horace Krever, Commission of Inquiry on the Blood System in Canada, Final report, Volume 3, p. 1055.

Advise and make recommendations to the the Board of Directors and Management Committee on the safety and quality of all products for recipients which are manufactured and/or distributed by Héma-Québec, the services offered by Héma-Québec with respect to donors' health.

More specifically the committee monitors:

  • any emerging risks that could affect the quality and safety of products as well as donors' health;
  • all developments concerning the measures to be taken regarding the quality and safety of products;
  • any other issue to reduce the quality and safety risks associated to the products and donors' health.

The committee is composed of a minimum of ten (10) external voting members, including a representative from Canadian Blood Services. The Board of Directors appoints the external members after reviewing their curriculum vitae with the exception of one member appointed by the Advisory Committee of Recipients' Representatives.

The member selection process must take into account the following fields:

Fields
Infectious diseases
Public health
Transfusion medicine and practice
Donor
Epidemiology
Ethics and law
Representative of the public
Human tissues and sickle cells

Back